Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| ciliated cell | 13 studies | 39% ± 11% | |
| epithelial cell | 8 studies | 33% ± 17% | |
| endothelial cell | 7 studies | 28% ± 18% | |
| type I pneumocyte | 6 studies | 31% ± 15% | |
| type II pneumocyte | 6 studies | 34% ± 20% | |
| club cell | 6 studies | 30% ± 8% | |
| basal cell | 5 studies | 34% ± 21% | |
| squamous epithelial cell | 4 studies | 36% ± 20% | |
| secretory cell | 4 studies | 21% ± 3% | |
| goblet cell | 4 studies | 35% ± 26% | |
| respiratory goblet cell | 4 studies | 41% ± 10% | |
| cholangiocyte | 3 studies | 43% ± 23% | |
| luminal cell of prostate epithelium | 3 studies | 24% ± 7% | |
| mucus secreting cell | 3 studies | 31% ± 6% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| lung | 5 studies | 27% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 100% | 2101.25 | 576 / 578 | 99% | 50.51 | 1148 / 1155 |
| pancreas | 100% | 2551.42 | 328 / 328 | 98% | 67.22 | 175 / 178 |
| prostate | 96% | 3942.45 | 236 / 245 | 100% | 63.49 | 502 / 502 |
| thymus | 100% | 2395.62 | 653 / 653 | 96% | 19.57 | 581 / 605 |
| breast | 100% | 1250.19 | 457 / 459 | 94% | 24.73 | 1051 / 1118 |
| liver | 100% | 2529.04 | 226 / 226 | 90% | 34.51 | 366 / 406 |
| stomach | 84% | 4895.53 | 300 / 359 | 98% | 67.19 | 280 / 286 |
| bladder | 76% | 1105.29 | 16 / 21 | 98% | 46.80 | 496 / 504 |
| intestine | 65% | 1798.42 | 630 / 966 | 99% | 66.95 | 520 / 527 |
| esophagus | 63% | 1515.04 | 905 / 1445 | 99% | 75.35 | 182 / 183 |
| uterus | 65% | 410.32 | 111 / 170 | 91% | 40.97 | 417 / 459 |
| kidney | 100% | 1508.38 | 89 / 89 | 49% | 10.50 | 445 / 901 |
| skin | 92% | 1812.22 | 1661 / 1809 | 56% | 14.78 | 263 / 472 |
| adrenal gland | 100% | 2763.25 | 258 / 258 | 33% | 13.98 | 77 / 230 |
| ovary | 11% | 50.89 | 20 / 180 | 99% | 35.22 | 426 / 430 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 40.97 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 48.41 | 1 / 1 |
| adipose | 97% | 768.65 | 1162 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 95% | 27.45 | 76 / 80 |
| heart | 40% | 192.12 | 347 / 861 | 0% | 0 | 0 / 0 |
| spleen | 31% | 129.24 | 75 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 6.19 | 7 / 29 |
| muscle | 23% | 107.76 | 181 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 18% | 244.88 | 165 / 929 | 0% | 0 | 0 / 0 |
| blood vessel | 8% | 41.10 | 107 / 1335 | 0% | 0 | 0 / 0 |
| brain | 1% | 3.35 | 20 / 2642 | 1% | 0.07 | 4 / 705 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032956 | Biological process | regulation of actin cytoskeleton organization |
| GO_0051017 | Biological process | actin filament bundle assembly |
| GO_0030838 | Biological process | positive regulation of actin filament polymerization |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0051764 | Biological process | actin crosslink formation |
| GO_0007009 | Biological process | plasma membrane organization |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_0005912 | Cellular component | adherens junction |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0098641 | Molecular function | cadherin binding involved in cell-cell adhesion |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| GO_0070064 | Molecular function | proline-rich region binding |
| Gene name | BAIAP2L1 |
| Protein name | Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 (BAI1-associated protein 2-like protein 1) (Insulin receptor tyrosine kinase substrate) |
| Synonyms | IRTKS |
| Description | FUNCTION: May function as adapter protein. Involved in the formation of clusters of actin bundles. Plays a role in the reorganization of the actin cytoskeleton in response to bacterial infection. . |
| Accessions | Q9UHR4 ENST00000005260.9 |